Drug delivery researchers have vastly improved the potential of genetic therapies by overcoming the challenge of consistently ...

The tiny fatty capsules that deliver COVID-19 mRNA vaccines into billions of arms may work better when they're a little ...

Co‑injecting three common amino acids with LNPs dramatically boosted both mRNA delivery and CRISPR gene editing efficiency in ...

Johns Hopkins Medicine scientists say they have developed a simplified version of biodegradable nanoparticles that can ...

Allied Market Research published a report, titled, "Lipid Nanoparticles Market by Type (Solid Lipid Nanoparticles, ...

Silica nanoparticles may make oral insulin possible by safely enhancing drug absorption through the intestinal wall in obese mice.

Researchers have discovered that how water binds to nanoparticles can determine whether a nanomedicine works or fails. A key finding.

Better mRNA release inside cells boosts vaccine and gene editing performance, enabled by redesigned lipid molecules that grip ...

Lipid nanoparticles, or LNPs, are best known as the delivery system used in the COVID-19 mRNA vaccines given to billions of people worldwide. Scientists are now exploring their potential far beyond ...

A small shift in temperature is enough to make a new class of nanoparticles snap together, offering a novel way to deliver fragile medicines. Researchers at the University of Chicago Pritzker School ...

Across the U.S., hundreds of sites on land or in lakes and rivers are heavily contaminated with hazardous waste produced by ...

Delray Beach, FL, Oct. 01, 2024 (GLOBE NEWSWIRE) -- The global lipid nanoparticles market is on track to grow from USD 271.8 million in 2024 to USD 350.5 million by 2029, driven by advancements in ...